Danaher Exceeds Expectations with Strong Third Quarter 2025 Performance

Danaher Corporation (NYSE: DHR) announced third quarter 2025 results that exceeded expectations, with net earnings of $908 million or $1.27 per diluted common share and non-GAAP adjusted diluted net earnings per common share of $1.89. The company reported revenues increased 4.5% year-over-year to $6.1 billion, while non-GAAP core revenue grew 3.0% year-over-year. Operating cash flow reached $1.7 billion and non-GAAP free cash flow was $1.4 billion for the quarter ended September 26, 2025.

President and Chief Executive Officer Rainer M. Blair stated that the company's performance was driven by DBS-driven execution combined with continued momentum in the bioprocessing business and better-than-anticipated respiratory revenue at Cepheid. These factors enabled Danaher to exceed revenue, earnings and cash flow expectations for the quarter. Blair emphasized the company's ongoing focus on delivering value for customers, associates, and shareholders through investments in breakthrough innovation, enhanced commercial execution, and meaningful productivity gains across all business units.

For full year 2025, Danaher is maintaining its adjusted diluted net earnings per common share guidance range of $7.70 to $7.80. The company expects non-GAAP core revenue to grow low-single digits year-over-year for the full year. The company does not reconcile non-GAAP forecasted core sales growth and adjusted diluted net earnings per common share to GAAP measures due to the difficulty in predicting additional elements such as currency exchange rate impacts on profitability, acquisitions, divested product lines, discrete tax adjustments, impairments, gains and losses on investments, and legal proceedings outcomes.

Danaher's strong performance in the third quarter demonstrates the effectiveness of its operational strategies and positions the company to continue addressing significant healthcare challenges globally. The company's ability to exceed expectations despite market challenges highlights its resilient business model and strategic focus areas. Additional information about Danaher's corporate mission and focus can be found at https://www.danaher.com.